All News

Dr. Alexander Spira explained the difference between a clinical trial and a real-world study in a CURE interview for patients with lung cancer.

Cancer during pregnancy is rare but increasingly recognized as maternal age rises and non-invasive prenatal testing becomes more common.

Ibtrozi may become the new standard for ROS1-mutated lung cancer, with phase 2 data showing safer, longer-lasting benefits for patients.

Urothelial carcinoma, the most common type of bladder cancer, is explained from diagnosis to treatment.

As a metastatic breast cancer patient, I want to control what I can, including my diet and exercise.

This in-depth guide offers a clear look at papillary thyroid cancer, from initial diagnosis and treatment options to long-term prognosis and living well after treatment.

Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer.

Adrenal cancer is rare, but surgery, medicines, chemotherapy and clinical trials can help patients based on stage, spread and overall health.

Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.

Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate to treatment decisions.

The NY Giants Legend To Celebrate Being Cancer Free At The NFL Giants Crucial Catch Game September 28th at MetLife Stadium.

Inluriyo, an oral therapy for ER+, HER2– metastatic breast cancer with ESR1 mutations, offers a new treatment option after prior endocrine therapy.

Tending my garden and observing nature teaches me resilience, presence, and growth, helping me carry joy and sorrow while living with Lynch syndrome.

Women with a history of cervical cancer are nearly twice as likely to develop anal cancer as members of the general population, according to researchers.

A study found that iberdomide with Darzalex and dexamethasone helped more patients with multiple myeloma reach no signs of cancer after treatment.

Dr. David A. Taub sat down with CURE for an interview in honor of Prostate Cancer Awareness Month, observed annually each September.

Heather Ann Yonker, emphasizes the importance of food safety practices for patients with cancer, particularly those with weakened immune systems.

As a 12-year survivor of myelodysplastic syndrome, I’ve learned that each of us faces cancer our own way, and in the end, we can say we lived life our way.

The FDA granted priority review to an sBLA for first-line treatment with Enhertu plus Perjeta in unresectable or metastatic HER2-positive breast cancer.

Pancreatic cancer remains one of the deadliest cancers because it is often detected at an advanced stage when treatment options are limited.

The FDA grants fast track status to alnodesertib plus low-dose irinotecan for third-line metastatic colorectal cancer with ATM deficiency.

After a stage 3b rectal cancer diagnosis, one patient endured radiation, chemotherapy, surgery, and complications, relying on resilience, advocacy and support.

I’ve lived 22 years beyond my breast cancer diagnosis, and each day I honor survival with gratitude, wellness, and hope for myself and others.

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment.

Dr. Christina Cho explains that a strong transplant program provides advanced treatments along with a supportive team for patients with blood cancers.

LiveLung announced the launch of its new Chaplain Program.

This Prostate Cancer Awareness Month, join our free Men's Health Event.

Going through breast cancer has pushed me to do things I never thought I would.